Document is current
Any future updates will be listed below
-
Authors
Hu, Tianyan
Done, Nicolae
Petigara, Tanaz
Mohanty, Salini
Song, Yan
Liu, Qing
Lemus-Wirtz, Esteban
Signorovitch, James
Sarpong, Eric
Weiss, Thomas
-
Funding
Funding for this research was provided by:
Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ USA
- License Information
-
More Information
Article History
Received: 21 June 2021
Accepted: 22 February 2022
First Online: 26 March 2022
Declarations
:
: This study involved de-identified, aggregate data from a pre-existing dataset that was licensed to Merck & Co., Inc., and was not subject to Institutional Review Board approval at Merck & Co., Inc. or Analysis Group, Inc. Informed consent was not needed as all patients were anonymyzed and only aggregate data are reported here. A research review committee at Merck & Co., Inc. approved the study protocol prior to the study initiation. All methods were performed in accordance with the relevant guidelines and regulations, including the principles of the Declaration of Helsinki.
: Not applicable.
: TH, TP, SM, ES, and TW are employees of Merck & Co., Inc. and may own stock/stock options. ND, YS, QL, ELW, and JS are employees of Analysis Group, Inc., a consulting firm that received funding from Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ USA, to conduct this study.
